Product Information
CLONAZEPAM 0.5 MG DIS TABLET is a generic product labeled by Par Health USA, LLC, priced at $0.4994 per EA under NDC 49884030802. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
.5 mg/1
Manufacturer
Par Health USA, LLCNDC
49884030802
Classification
Generic
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077171On Market Since
8/5/2005
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 0.5 MG DIS TABLET has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 29.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4994 per EA |
|---|---|
| All-time high | $0.8205 (Jun 15, 2022) |
| All-time low | $0.3899 (Jul 17, 2024) |
| 52-week high | $0.6045 |
| 52-week low | $0.4889 |
| Median price | $0.6612 |
| Average price | $0.6382 |
| Largest weekly change | +48.4% (Aug 21, 2024) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 5 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 5 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 96% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of CLONAZEPAM 0.5 MG DIS TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 0.5 MG DIS TABLET, manufactured by Par Health USA, LLC, is $0.4994 per EA (NDC 49884030802), effective Jun 24, 2026.
How has the price of CLONAZEPAM 0.5 MG DIS TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 0.5 MG DIS TABLET has declined 29.6%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 0.5 MG DIS TABLET?
Since Nov 28, 2013, the NADAC for CLONAZEPAM 0.5 MG DIS TABLET has ranged from a low of $0.3899 (Jul 17, 2024) to a high of $0.8205 (Jun 15, 2022), with a median of $0.6612 per EA.
Are there cheaper alternatives to CLONAZEPAM 0.5 MG DIS TABLET?
Yes. 5 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, CLONAZEPAM 0.5 MG TABLET, is $0.0199 per EA — about 96% below CLONAZEPAM 0.5 MG DIS TABLET.
Who manufactures CLONAZEPAM 0.5 MG DIS TABLET?
CLONAZEPAM 0.5 MG DIS TABLET (NDC 49884030802) is labeled by Par Health USA, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification